EvoPlexus Medics ApS: Financial statements 2022
CVR: 40782001
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
EvoPlexus Medics ApS (CVR 40782001) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -77,745 and a net result of DKK -77,761 compared with DKK -47,379 the year before. Equity in the 2022 report amounted to DKK -95,068.
- Gross Profit
- DKK -77,745
- Profit/Loss
- DKK -77,761
- Equity
- DKK -95,068
- Total Assets
- DKK 40,018
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -78 t. | -78 t. | -95 t. | - |
| 2021 | - | -47 t. | -47 t. | -17 t. | 0 |
Official annual report
Keep an eye on EvoPlexus Medics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
EvoPlexus Medics ApS has published its annual report for 2021. Gross profit came to DKK -47,379, and the net result was DKK -47,379.
About EvoPlexus Medics ApS
EvoPlexus Medics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Computerprogrammering. The management consists of Serkawt Khola. The company is owned by EvoPlexus Holding ApS. According to the 2021 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -50,496 and a net result of DKK -50,498 compared with DKK -38,945 the year before. Equity in the 2025 report amounted to DKK -249,603.